Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting. (May 2021) - Bettelli, Stefania; Marcheselli, Raffaella; Pozzi, Samantha; Marcheselli, Luigi; Papotti, Robel; Forti, Elisa; Cox, M. Christina Christina; Di Napoli, Arianna; Tadmor, Tamar; Mansueto, Giovanna R.; Musto, Pellegrino; Flenghi, Leonardo; et al.